Skip to main content
. 2023 Jul 11;10(7):ofad348. doi: 10.1093/ofid/ofad348

Table 6.

Adverse Reactions Among Case Series

Adverse Reactions No. (%)
Patients with adverse reactions No. of patients who reported adverse reaction 133 (40.67)
Impact on the treatment Treatment unchanged 112 (84.21)
Treatment modified (dose/length/etc.) 10 (7.52)
Treatment discontinued 11 (8.27)
Patients included (with or without adverse reactions) Total No. of patients included 327 (100)
Adverse reaction categories Renal insufficiency/toxicity 79 (43.89)
Electrolytes disorders 12 (6.67)
Infusion reaction 50 (27.78)
Rash/cutaneous reaction 1 (0.56)
GI symptoms 18 (10.00)
Cardiac toxicity 2 (1.11)
Anaphylaxis 2 (1.11)
Other 31 (17.22)
Total No. of events Total No. of adverse reactions reported 180 (100)